ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 60 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,000 | -25.0% | 33,918 | 0.0% | 0.00% | – |
| Q2 2022 | $8,000 | 0.0% | 33,918 | +12.4% | 0.00% | – |
| Q1 2022 | $8,000 | -52.9% | 30,168 | -3.2% | 0.00% | – |
| Q4 2021 | $17,000 | -46.9% | 31,168 | 0.0% | 0.00% | – |
| Q3 2021 | $32,000 | -22.0% | 31,168 | +3.3% | 0.00% | – |
| Q2 2021 | $41,000 | -19.6% | 30,168 | +1.7% | 0.00% | – |
| Q1 2021 | $51,000 | +920.0% | 29,663 | +531.1% | 0.00% | – |
| Q4 2020 | $5,000 | 0.0% | 4,700 | +18.4% | 0.00% | – |
| Q3 2020 | $5,000 | +25.0% | 3,970 | 0.0% | 0.00% | – |
| Q2 2020 | $4,000 | -63.6% | 3,970 | -58.9% | 0.00% | – |
| Q1 2020 | $11,000 | – | 9,651 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,574,060 | $27,874,000 | 1.68% |
| SENZAR ASSET MANAGEMENT, LLC | 798,381 | $3,385,000 | 0.58% |
| Cormorant Asset Management, LP | 850,000 | $3,604,000 | 0.48% |
| Palo Alto Investors LP | 2,135,739 | $9,056,000 | 0.40% |
| Opus Point Partners Management, LLC | 99,959 | $424,000 | 0.34% |
| Granahan Investment Management | 1,582,237 | $6,709,000 | 0.19% |
| Joel Isaacson & Co., LLC | 70,660 | $300,000 | 0.08% |
| MARINER INVESTMENT GROUP LLC | 59,700 | $253,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $318,000 | 0.06% |
| Cornerstone Capital, Inc. | 59,200 | $251,000 | 0.06% |